Oculis Holding AG OCS
NASDAQ OCS
$12.17 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Oculis Holding AG (OCS) Long-Term Investments (2023 - 2025)

Oculis Holding AG (OCS) posted quarterly Long-Term Investments of $239.1 million for Q4 2025, up 9.61% year-over-year from $218.1 million in Q4 2024, and up 9.61% quarter-over-quarter from $218.1 million in Q4 2024.

Analysis

Oculis Holding AG (OCS) Long-Term Investments (2023 - 2025) Analysis & Trends

Oculis Holding AG's Long-Term Investments history runs 5 years deep, the most recent figure standing at $239.1 million for Q4 2025.

  • In Q4 2025, Long-Term Investments rose 9.61% year-over-year to $239.1 million; the TTM figure through Dec 2025 stood at $239.1 million (up 9.61% YoY), while the FY2025 annual figure was $230.5 million, up 6.11% from the prior year.
  • Long-Term Investments for Q4 2025 stood at $239.1 million, up from $218.1 million in the prior quarter.
  • The five-year high for Long-Term Investments was $239.1 million in Q4 2025, with the low at $51901.1 in Q4 2022.
  • The 5-year median for Long-Term Investments is $215.4 million (2023), against an average of $134.5 million.
  • The sharpest annual moves came in 2022 and 2023: Long-Term Investments declined 7.97% in 2022, then soared 414920.6% in 2023.
  • Oculis Holding AG's Long-Term Investments stood at $56394.1 in 2021, then decreased by 7.97% to $51901.1 in 2022, then jumped by 414920.6% to $215.4 million in 2023, then rose by 1.26% to $218.1 million in 2024, then increased by 9.61% to $239.1 million in 2025.
  • Business Quant data shows OCS's Long-Term Investments at $239.1 million in Q4 2025, $218.1 million in Q4 2024, and $215.4 million in Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 5.79 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 9.83 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -4.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 1.77 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 22.17 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 372.10 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Oculis Holding AG 634.75 Mn 345.87 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 239.06 Mn
Dec 31, 2024 218.11 Mn
Dec 31, 2023 215.40 Mn